Bioabsorbable stents in routine practice. New epoch in interventional cardiology

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F17%3A00000352" target="_blank" >RIV/61383082:_____/17:00000352 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/17:10364465

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S0010865016300625" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0010865016300625</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2016.11.007" target="_blank" >10.1016/j.crvasa.2016.11.007</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Bioabsorbable stents in routine practice. New epoch in interventional cardiology

Popis výsledku v původním jazyce

Introduction: According to contemporary experience, bioabsorbable vascular scaffolding (BVS) implantation represents promising perspective in cardiology interventions. In the cathlab of Central Military Hospital in Prague, the program of BVS implantation started in June 2013. Patient cohort and methods: From June 2013 to October 2015, 107 procedures of BVS implantation in 98 patients were performed. Total of 110 lesions were treated. In 9 patients BVS was implanted in two stages. In 3 patients, the intervention of two vessels was performed during one procedure, always using BVS. Non-randomized data of three cohorts of patients were evaluated: STEMI (45 patients), NSTEMI (34 patients), and elective BVS implantations (31 patients). The three groups did not differ in basic demographic features. In STEMI group, initial thrombotic occlusion and consequent thrombaspiration were more often. In this (STEMI) group, the evaluation of the procedure is supplemented by CT performance after 12 months. Results: The procedure was always technically successful except 1 case (NSTEMI). Residual diameter stenosis >20% was registered in 1 patient in each group. Except 1 case in STEMI group, final TIMI III flow was achieved in all cases. One patient died in NSTEMI group in consequence of definite stent thrombosis. The final angiographic result (recoil, residual stenosis) was evaluated with the aid of quantitative coronary analysis (QCA). It did not prove any statistically significant difference among the groups. The value of immediate recoil did not exceed 10% in all groups. Target lesion revascularization (TLR) was performed in two patients in STEMI group. Up to now, performed CT scans demonstrated persisting good results. Conclusion: In accordance with contemporary literary data, our experience proves safety and efficacy of BVS implantation during coronary interventions in selected patients. (C) 2016 Published by Elsevier Sp. zo.o. on behalf of The Czech Society of Cardiology.

Název v anglickém jazyce

Bioabsorbable stents in routine practice. New epoch in interventional cardiology

Popis výsledku anglicky

Introduction: According to contemporary experience, bioabsorbable vascular scaffolding (BVS) implantation represents promising perspective in cardiology interventions. In the cathlab of Central Military Hospital in Prague, the program of BVS implantation started in June 2013. Patient cohort and methods: From June 2013 to October 2015, 107 procedures of BVS implantation in 98 patients were performed. Total of 110 lesions were treated. In 9 patients BVS was implanted in two stages. In 3 patients, the intervention of two vessels was performed during one procedure, always using BVS. Non-randomized data of three cohorts of patients were evaluated: STEMI (45 patients), NSTEMI (34 patients), and elective BVS implantations (31 patients). The three groups did not differ in basic demographic features. In STEMI group, initial thrombotic occlusion and consequent thrombaspiration were more often. In this (STEMI) group, the evaluation of the procedure is supplemented by CT performance after 12 months. Results: The procedure was always technically successful except 1 case (NSTEMI). Residual diameter stenosis >20% was registered in 1 patient in each group. Except 1 case in STEMI group, final TIMI III flow was achieved in all cases. One patient died in NSTEMI group in consequence of definite stent thrombosis. The final angiographic result (recoil, residual stenosis) was evaluated with the aid of quantitative coronary analysis (QCA). It did not prove any statistically significant difference among the groups. The value of immediate recoil did not exceed 10% in all groups. Target lesion revascularization (TLR) was performed in two patients in STEMI group. Up to now, performed CT scans demonstrated persisting good results. Conclusion: In accordance with contemporary literary data, our experience proves safety and efficacy of BVS implantation during coronary interventions in selected patients. (C) 2016 Published by Elsevier Sp. zo.o. on behalf of The Czech Society of Cardiology.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

59

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

1

Strana od-do

"E251-E256"

Kód UT WoS článku

000410032200007

EID výsledku v databázi Scopus

—